ZM 323881 hydrochloride 10mg 10mg | Purity Not Available
Adooq Bioscience
ZM 323881 is a potent and selective inhibitor of the kinase activity of the human vascular endothelial growth factor receptor 2 (VEGFR2/KDR).
More Information Supplier PageSearch Results
AMD 3465 Hexahydrobromide 50mg 50mg | Purity Not Available
Adooq Bioscience
AMD 3465 Hexahydrobromide 25mg 25mg | Purity Not Available
Adooq Bioscience
AMD 3465 Hexahydrobromide 100mg 100mg | Purity Not Available
Adooq Bioscience
AMD 3465 Hexahydrobromide 10mg 10mg | Purity Not Available
Adooq Bioscience
P505-15 50mg 50mg | Purity Not Available
Adooq Bioscience
P505-15 (also known as PRT062607) is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.
More Information Supplier PageP505-15 5mg 5mg | Purity Not Available
Adooq Bioscience
P505-15 (also known as PRT062607) is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.
More Information Supplier PageAP26113 10mg 10mg | Purity Not Available
Adooq Bioscience
AP26113 has exhibited activity as a potent dual inhibitor of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR).
More Information Supplier PageTCN 201 50mg 50mg | Purity Not Available
Adooq Bioscience
TCN 201 is a NMDA receptor antagonist selective for NR1/NR2A over NR1/NR2B-containing receptors
More Information Supplier PageTCN 201 25mg 25mg | Purity Not Available
Adooq Bioscience
TCN 201 is a NMDA receptor antagonist selective for NR1/NR2A over NR1/NR2B-containing receptors
More Information Supplier Page